ArticleNeoplasia (New York, N.Y.)2015

Successful combination of sunitinib and girentuximab in two renal cell carcinoma animal models: a rationale for combination treatment of patients with advanced RCC.

Jeannette C Oosterwijk-Wakka et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.